ACTRN12612000326897招募中未知
Circulating Tumour DNA as a Marker of Occult Disease in Stage II Colorectal Cancer and Response to Therapy in Metastatic Colorectal Cancer
udwig Institute for Cancer Research0 个研究点目标入组 290 人开始时间: 2012年3月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 290
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Patients with histologically confirmed primary colorectal cancer
- •For the stage II colon cancer (cohort A)
- •-Patients with curatively resected stage II primary colon cancer
- •-Patients must be registered for study within 10 weeks of surgery
- •For the metastastic (stage IV) colorectal cancer (cohort B)
- •-Patients with measurable disease by RECIST criteria version 1.1
- •-Patients fit to receive standard first line combination chemotherapy, with cytotoxic agents and any biological therapy given at standard doses.
- •ECOG performance status 0 - 2
- •Patients willing to provide written informed consent
排除标准
- •1. History of another primary cancer within the last 5 years, with the exception of non-melanomatous skin cancer and carcinoma in situ of the cervix.
- •2. Medical or psychiatric condition or occupational responsibilities that may preclude compliance with the protocol.
- •3. Patients with major organ impairment.
- •4. Patients that are not accessible for follow-up.
研究者
相似试验
尚未招募
不适用
Circulating Tumour DNA as a Marker of Complete Pathological Response and Long Term Outcome for Locally Advanced Rectal Cancer Treated with Pre-operative ChemoradiotherapyACTRN12612000327886udwig Institute for Cancer Research320
招募中
不适用
Circulating Tumour DNA as a Sensitive and Specific Marker of Response to Therapy and of Occult Disease in Colorectal CancerPatients with resectable colorectal cancer liver metastasesCancer - Bowel - Back passage (rectum) or large bowel (colon)ACTRN12612000345886udwig Institute for Cancer Research100
招募中
不适用
Circulating Tumour DNA in Stage 1 to 4 Ovarian CancerOvarian cancerACTRN12617001119381Walter and Eliza Hall Institute of Medical Research100
招募中
不适用
Circulating tumor DNA as a noninvasive biomarker in patients with thyroid cancerC73Malignant neoplasm of thyroid glandDRKS00022441niversitätsklinikum Freiburg75
招募中
不适用
Circulating tumor DNA as a noninvasive biomarker in patients with Non-Hodgkin Lymphoma (NHL)C83.3C85Diffuse large B-cell lymphomaOther and unspecified types of non-Hodgkin lymphomaDRKS00024180niversitätsklinikum Freiburg200